Latest News

2 men charged in Florida after video shows beer poured in gator’s mouth

MARTIN COUNTY, Fla. (WISH) — Two men in Florida have been charged after a video posted to social media showed beer being poured into an alligator’s mouth.

WPBF reports that Timothy Kepke and Noah Osborne faces charges in the case. They were arrested last week.

The investigation started after wildlife officials received complaints about the video in August.

The video shows Kepke trying to get the small alligator to bite onto his arm, which it does. Beer is then poured down the gator’s throat.

Police say Kepke admitted to being the man in the video. Osbourne says he caught the gator with his bare hands.

They both face charges of unlawfully taking an alligator. They’ve been released on bond.

Information from CNN Newsource was used in this report.


Elanco closes out first full year of independence

GREENFIELD, Ind. (Inside INdiana Business) — Elanco Animal Health Inc. (NYSE: ELAN) is reporting full-year net income of nearly $68 million in 2019, down from $86.5 million the previous year. 2019 marked the first full year for Elanco as an independent, public company. It separated from Indianapolis-based Eli Lilly and Co. (NYSE: LLY) in 2018.

The company is also reporting a fourth-quarter net loss of $9.5 million, compared to net income of $16.4 during the same period a year ago.

Elanco President and Chief Executive Officer Jeff Simmons says the company is moving with “speed and agility” like never before.

“We are advancing our pipeline, executing across a diverse portfolio and improving profitability through a robust productivity agenda,” said Simmons. “We remain confident in the underlying fundamentals in our base business.”

Simmons says the acquisition of Bayer Animal Health is developing better than expected. In August, Elanco announced it was purchasing the animal health assets from Germany-based Bayer AG in a deal valued at $7.6 billion.

“We are encouraged by the progress from a regulatory, financing and integration planning perspective, as well as, Bayer’s underlying market positioning and performance. We continue to look toward a mid-2020 close.”

If approved, it would double Elanco’s Companion Animal business and create the second-largest animal health company by revenue.

To view the complete earnings report, click here.